ITB-Med LLC
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients (NCT06453668) | ITB-Med LLC | 2024-04-16 |
| A Study of TCD601 in de Novo Renal Transplant Recipients (NCT05669001) | ITB-Med LLC | 2023-12-28 |
| A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE) (NCT04803058) | ITB-Med LLC | 2022-12-14 |
| A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation (NCT06019507) | ITB-Med LLC | 2022-06-29 |
| A Dose Escalation Study in de Novo Renal Transplantation (NCT04311632) | ITB-Med LLC | 2021-05-26 |
Track ITB-Med LLC automatically
Every clearance here is in the API, with alerts when new ones post.